NEW YORK (GenomeWeb News) — Caliper Life Sciences today said third-quarter revenues increased 24 percent as R&D spending more than doubled and losses surged 250 percent.
 
Total receipts for the three months ended Sept. 30 increased to $26.5 million from $21.3 million year over year. Most of that revenue came from product sales, which brought in $18.5 million, while services brought in $6 million and licensing and contracts earned $2 million. 
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.